Results of heart transplantation in patients with preexisting malignancies.
Twenty patients with end-stage heart failure and preexisting malignancies underwent heart transplantation at a single center, with a neoplasm-free interval before the procedure of 0 to 240 months. Twelve patients were long-term survivors (2 to 72 months); there were 2 early and 6 late deaths, thus justifying heart transplantation in patients with preexisting malignancies in individual cases.
Koerner
M M
MM
Heart Center Northrhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germany.
Tenderich
G
G
Minami
K
K
Mannebach
H
H
Koertke
H
H
zu Knyphausen
E
E
El-Banayosy
A
A
Baller
D
D
Kleesiek
K
K
Gleichmann
U
U
Meyer
H
H
Koerfer
R
R
D000075202:Contraindications; D005260:Female; D005500:Follow-Up Studies; D006331:Heart Diseases / Q000150:complications / Q000453:epidemiology / Q000601:surgery*; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000453:epidemiology* / Q000628:therapy; D018579:Patient Selection; D011379:Prognosis; D016019:Survival Analysis; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome